Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study. | Front Oncol | 2023 | 37333831 | PubTator, text mining | PubMed |
| NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma. | Front Oncol | 2023 | 37333821 | PubTator, text mining | PubMed |
| Bridging the simulation-to-real gap for AI-based needle and target detection in robot-assisted ultrasound-guided interventions. | Eur Radiol Exp | 2023 | 37332035 | PubTator, text mining | PubMed |
| Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity. | Pilot Feasibility Stud | 2023 | 37328890 | PubTator, text mining | PubMed |
| Single cell profiling of female breast fibroadenoma reveals distinct epithelial cell compositions and therapeutic targets. | Nat Commun | 2023 | 37328469 | PubTator, text mining | PubMed |
| Primary central nervous system lymphoma. | Nat Rev Dis Primers | 2023 | 37322012 | PubTator, text mining | PubMed |
| 5-Methylcytosine-related lncRNAs: predicting prognosis and identifying hot and cold tumor subtypes in head and neck squamous cell carcinoma. | World J Surg Oncol | 2023 | 37312123 | PubTator, text mining | PubMed |
| Real-World Data Analysis of Survival Outcomes and Central Nervous System Relapses in Testicular Diffuse Large B Cell Lymphoma. | Cancer Manag Res | 2023 | 37304895 | PubTator, text mining | PubMed |
| Recent advances and challenges in primary central nervous system lymphoma: a narrative review. | Transl Cancer Res | 2023 | 37304530 | PubTator, text mining | PubMed |
| Beyond monoclonal gammopathy of undetermined significance, clinical spectrum of immunoglobulin M gammopathy: a case series with focus on the diagnostic and management challenges. | Int J Hematol Oncol | 2023 | 37304326 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of Gene Expression Profiles for Diagnosing Sepsis and Risk Prediction in Patients with Sepsis. | Int J Mol Sci | 2023 | 37298316 | PubTator, text mining | PubMed |
| Strategies for Reducing Toxicity and Enhancing Efficacy of Chimeric Antigen Receptor T Cell Therapy in Hematological Malignancies. | Int J Mol Sci | 2023 | 37298069 | PubTator, text mining | PubMed |
| Autotaxin Inhibition with IOA-289 Decreases Breast Tumor Growth in Mice Whereas Knockout of Autotaxin in Adipocytes Does Not. | Cancers (Basel) | 2023 | 37296899 | PubTator, text mining | PubMed |
| Combination of High-Resolution Structures for the B Cell Receptor and Co-Receptors Provides an Understanding of Their Interactions with Therapeutic Antibodies. | Cancers (Basel) | 2023 | 37296844 | PubTator, text mining | PubMed |
| A survey evaluating hematology physicians’ perspectives on central nervous system prophylaxis. | Blood Res | 2023 | 37292008 | PubTator, text mining | PubMed |
| Primary testicular lymphoma demonstrates overexpression of the Wilms tumor 1 gene and different mRNA and miRNA expression profiles compared to nodal diffuse large B-cell lymphoma. | Hematol Oncol | 2023 | 37291944 | PubTator, text mining | PubMed |
| B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma. | Nat Commun | 2023 | 37291228 | PubTator, text mining | PubMed |
| SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022). | Clin Transl Oncol | 2023 | 37289353 | PubTator, text mining | PubMed |
| Risk prediction model construction for post myocardial infarction heart failure by blood immune B cells. | Front Immunol | 2023 | 37287974 | PubTator, text mining | PubMed |
| The potential of FCRL genes as targets for cancer treatment: insights from bioinformatics and immunology. | Aging (Albany NY) | 2023 | 37285836 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=32